Apellis Pharmaceuticals (APLS) Stock Price
$18.3 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Apellis Pharmaceuticals, AI stock picks, stock alerts and much more.
APLS AI Stock Analysis
AI stock analysis for APLS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Apellis Pharmaceuticals (APLS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Apellis Pharmaceuticals (APLS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Apellis Pharmaceuticals (APLS), currently trading at $18.3, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About APLS
-
Apellis Pharmaceuticals, Inc.
-
Symbol
APLS
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.3B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.67 0.6% |
6 |
 |
Inovio Pharmaceuticals INO |
$2 0.00% |
3 |
 |
Moderna MRNA |
$26 2.5% |
3 |
 |
Anavex Life Sciences AVXL |
$8.61 7.2% |
7 |
 |
BridgeBio Pharma BBIO |
$41.14 3.4% |
7 |
News
APLS Alternative Data
Web Traffic
Apellis Pharmaceuticals receives an estimated 25198 monthly visitors to apellis.com.
-
Web Traffic
25198
-
Change from Previous Month
24.1%
-
3 Month Change
47.6%
-
YoY Change
47.6%
Twitter Followers
Apellis Pharmaceuticals has 1,642 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
1642
-
Daily Change
0.1%
-
1 Month Change
0.3%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Youtube Subscribers
Apellis Pharmaceuticals has 834 subscribers on its main Youtube channel, up by 0.2% over the last month.
-
Youtube Subscribers
834
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.2%
-
YoY Change
0.2%
LinkedIn Followers
82,490 are following Apellis Pharmaceuticals on LinkedIn, up by 1.1% over the last month.
-
LinkedIn Followers
82490
-
Daily Change
0%
-
1 Month Change
1.1%
-
3 Month Change
5.3%
Job Postings
Apellis Pharmaceuticals has an estimated 18 open job postings, which is down -18.2% over the last month.
-
Job Postings
18
-
Daily Change
0%
-
1 Month Change
18.2%
-
3 Month Change
71.4%
-
YoY Change
71.4%
LinkedIn Employees
According to LinkedIn, Apellis Pharmaceuticals has 767 employees, up by 1.9% over the last month.
-
LinkedIn Employees
767
-
Daily Change
0%
-
1 Month Change
1.9%
-
3 Month Change
1.3%
-
YoY Change
1.3%
Reddit Mentions
Apellis Pharmaceuticals has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Apellis Pharmaceuticals is 41 out of 100 (neutral).
-
Business Outlook
41
-
Change from Previous Month
8.9%
-
3 Month Change
6.8%
-
YoY Change
6.8%
News Mentions
Apellis Pharmaceuticals was mentioned 4 times in the news yesterday.
-
News Mentions
4
-
Daily Change
33.3%
-
1 Month Change
0%
-
3 Month Change
100%
App Downloads
-
App Downloads
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
APLS Financials
APLS Key Metrics
-
Total Revenue
$212.5M
-
Net Income
-$36.4M
-
Earnings per Share
-$0.29
-
Free cash flow
$19.3M
-
EBITDA
-$24.1M
-
EBITDA Ratio
-0.113298
-
Total Assets
$885.1M
APLS 2-year Revenue & Income
APLS 2-year Free Cash Flow
APLS Technicals
APLS SMA
APLS RSI
FAQ
What's the current price of Apellis Pharmaceuticals (APLS) Stock?
The price of an Apellis Pharmaceuticals (APLS) share is $18.3.
What's the market cap of Apellis Pharmaceuticals?
The current market cap of Apellis Pharmaceuticals is 2.3B.
Should I buy or sell APLS?
Apellis Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Apellis Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Apellis Pharmaceuticals a good investment?
The current analysis of Apellis Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Apellis Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Apellis Pharmaceuticals (APLS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Apellis Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Apellis Pharmaceuticals (APLS) that investors often compare it to?
Apellis Pharmaceuticals (APLS) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Apellis Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Apellis Pharmaceuticals' stock price to be around $17.3 in 2026. Starting from the current price of $18.3, this represents a 5.5% change in price, indicating a bearish outlook for the stock.
How to buy Apellis Pharmaceuticals (APLS) Stock?
Apellis Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Apellis Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.